The groundbreaking success of Sildenafil undeniably reshaped the drug landscape, but investing in companies strongly reliant on off-patent versions presents a challenging picture. Although early earnings were https://adult079500.ssnblog.com/40430525/viagra-and-the-pharmaceutical-industry-a-risky-stake